{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T03:11:06Z","timestamp":1770347466337,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,28]],"date-time":"2024-12-28T00:00:00Z","timestamp":1735344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["phiro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physics and Imaging in Radiation Oncology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.phro.2024.100693","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T08:11:14Z","timestamp":1735805474000},"page":"100693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Quantitative magnetic resonance imaging responses in head and neck cancer patients treated with magnetic resonance-guided hypofractionated radiation therapy"],"prefix":"10.1016","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4446-999X","authenticated-orcid":false,"given":"Ryan","family":"Bonate","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Musaddiq J.","family":"Awan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9676-6371","authenticated-orcid":false,"given":"Heather A.","family":"Himburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0447-871X","authenticated-orcid":false,"given":"Stuart","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5146-0240","authenticated-orcid":false,"given":"Monica","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7542-1094","authenticated-orcid":false,"given":"Sergey","family":"Tarima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1565-9628","authenticated-orcid":false,"given":"Joseph","family":"Zenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric S.","family":"Paulson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phro.2024.100693_b0005","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1002\/ijc.31937","article-title":"Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods","volume":"144","author":"Ferlay","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/j.phro.2024.100693_b0010","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fonc.2019.00827","article-title":"Diagnostic tumor markers in head and neck squamous cell carcinoma (HNSCC) in the clinical setting","volume":"9","author":"Economopoulou","year":"2019","journal-title":"Front Oncol"},{"issue":"Suppl 4","key":"10.1016\/j.phro.2024.100693_b0015","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S0959-8049(01)00462-2","article-title":"From chemoprevention and organ preservation programmes to postoperative management: major achievements and strategies of the EORTC Head and Neck Cancer Group","volume":"38","author":"Bernier","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.phro.2024.100693_b0020","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.oraloncology.2012.06.014","article-title":"Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis","volume":"48","author":"Ma","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.phro.2024.100693_b0025","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.clon.2015.02.001","article-title":"The radiobiology of hypofractionation","volume":"27","author":"Nahum","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.phro.2024.100693_b0030","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.radonc.2007.10.020","article-title":"Hypofractionated radiotherapy for the palliation of advanced head and neck cancer in patients unsuitable for curative treatment\u2013\u201cHypo Trial\u201d","volume":"85","author":"Porceddu","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100693_b0035","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.ijrobp.2010.03.028","article-title":"Adaptive dose painting by numbers for head-and-neck cancer","volume":"80","author":"Duprez","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100693_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41199-019-0046-z","article-title":"Adaptive radiotherapy for head and neck cancer","volume":"5","author":"Morgan","year":"2020","journal-title":"Cancers Head Neck"},{"key":"10.1016\/j.phro.2024.100693_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/jpm11111124","article-title":"Dynamics-Adapted Radiotherapy Dose (DARD) for head and neck cancer radiotherapy dose personalization","volume":"11","author":"Zahid","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.phro.2024.100693_b0050","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11051388","article-title":"Magnetic resonance guided radiotherapy for head and neck cancers","volume":"11","author":"Gharzai","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.phro.2024.100693_b0055","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2967\/jnumed.109.062638","article-title":"Dose painting in radiotherapy for head and neck squamous cell carcinoma: value of repeated functional imaging with (18)F-FDG PET, (18)F-fluoromisonidazole PET, diffusion-weighted MRI, and dynamic contrast-enhanced MRI","volume":"50","author":"Dirix","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.phro.2024.100693_b0060","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/mp.15130","article-title":"Multi-parametric MRI (mpMRI) for treatment response assessment of radiation therapy","volume":"49","author":"Wang","year":"2022","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2024.100693_b0065","article-title":"The correlation between apparent diffusion coefficient and tumor cellularity in patients: a meta-analysis","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phro.2024.100693_b0070","doi-asserted-by":"crossref","unstructured":"Surov A, Meyer HJ, Wienke A. Correlation between apparent diffusion coefficient (ADC) and cellularity is different in several tumors: a meta-analysis. Oncotarget 2017;8:59492\u20139. 10.18632\/oncotarget.17752.","DOI":"10.18632\/oncotarget.17752"},{"key":"10.1016\/j.phro.2024.100693_b0075","doi-asserted-by":"crossref","first-page":"e624","DOI":"10.5114\/pjr.2020.101476","article-title":"Intravoxel incoherent motion magnetic resonance imaging: basic principles and clinical applications","volume":"85","author":"Szubert-Franczak","year":"2020","journal-title":"Pol J Radiol"},{"key":"10.1016\/j.phro.2024.100693_b0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuroimage.2017.12.062","article-title":"What can we see with IVIM MRI?","volume":"187","author":"Le Bihan","year":"2019","journal-title":"Neuroimage"},{"key":"10.1016\/j.phro.2024.100693_b0085","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ijrobp.2018.03.028","article-title":"Emerging magnetic resonance imaging technologies for radiation therapy planning and response assessment","volume":"101","author":"Jones","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100693_b0090","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/lrb.2011.0010","article-title":"Quantification of lymphedema in a rat model by 3D-active contour segmentation by magnetic resonance imaging","volume":"10","author":"Sommer","year":"2012","journal-title":"Lymphat Res Biol"},{"key":"10.1016\/j.phro.2024.100693_b0095","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13244-022-01254-z","article-title":"T2 relaxation time for the early prediction of treatment response to chemoradiation in locally advanced rectal cancer","volume":"13","author":"Ge","year":"2022","journal-title":"Insights Imaging"},{"key":"10.1016\/j.phro.2024.100693_b0100","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/jmri.28597","article-title":"Time course changes of synthetic relaxation time during neoadjuvant chemotherapy in breast cancer: the optimal parameter for treatment response evaluation","volume":"58","author":"Zhao","year":"2023","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.phro.2024.100693_b0105","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0720-048X(99)00120-5","article-title":"Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI","volume":"33","author":"Lell","year":"2000","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.phro.2024.100693_b0110","doi-asserted-by":"crossref","first-page":"6303","DOI":"10.3390\/curroncol29090495","article-title":"Changes in Apparent Diffusion Coefficient (ADC) in serial weekly MRI during radiotherapy in patients with head and neck cancer: results from the PREDICT-HN study","volume":"29","author":"Ng","year":"2022","journal-title":"Curr Oncol"},{"key":"10.1016\/j.phro.2024.100693_b0115","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1002\/jmri.23885","article-title":"Changes in apparent diffusion coefficient and T2 relaxation during radiotherapy for prostate cancer","volume":"37","author":"Foltz","year":"2013","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.phro.2024.100693_b0120","doi-asserted-by":"crossref","first-page":"W164","DOI":"10.2214\/AJR.09.4122","article-title":"The postradiation neck: evaluating response to treatment and recognizing complications","volume":"195","author":"Glastonbury","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.phro.2024.100693_b0125","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1080\/0284186X.2021.1964699","article-title":"The effects of PD-1\/PD-L1 checkpoint inhibitors on recurrent\/metastatic head and neck squamous cell carcinoma: a critical review of the literature and meta-analysis","volume":"60","author":"Clarke","year":"2021","journal-title":"Acta Oncol"},{"key":"10.1016\/j.phro.2024.100693_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101426","article-title":"Therapeutic approaches for the treatment of head and neck squamous cell carcinoma-An update on clinical trials","volume":"21","author":"Goel","year":"2022","journal-title":"Transl Oncol"},{"key":"10.1016\/j.phro.2024.100693_b0135","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.phro.2024.100693_b0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.phro.2024.100693_b0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2019.01.018","article-title":"Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update","volume":"134","author":"Biau","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100693_b0150","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/1533034615572638","article-title":"Decision trees predicting tumor shrinkage for head and neck cancer: implications for adaptive radiotherapy","volume":"15","author":"Surucu","year":"2016","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.phro.2024.100693_b0155","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s00405-012-2117-1","article-title":"Head and neck squamous carcinomas with exophytic and endophytic type of growth have the same prognosis after surgery and adjuvant radiotherapy","volume":"270","author":"Harasymczuk","year":"2013","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.phro.2024.100693_b0160","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archotol.134.11.1196","article-title":"Analysis of prognostic factors in patients with oropharyngeal squamous cell carcinoma treated with radiotherapy alone or in combination with systemic chemotherapy","volume":"134","author":"Pedruzzi","year":"2008","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.phro.2024.100693_b0165","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.radonc.2020.09.046","article-title":"ADC measurements on the Unity MR-linac - A recommendation on behalf of the Elekta Unity MR-linac consortium","volume":"153","author":"Kooreman","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100693_b0170","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.radonc.2019.01.011","article-title":"Feasibility and accuracy of quantitative imaging on a 1.5 T MR-linear accelerator","volume":"133","author":"Kooreman","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100693_b0175","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/jmri.25411","article-title":"Evaluation of intravoxel incoherent motion fitting methods in low-perfused tissue","volume":"45","author":"Meeus","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.phro.2024.100693_b0180","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/mrm.25765","article-title":"Impact of the calculation algorithm on biexponential fitting of diffusion-weighted MRI in upper abdominal organs","volume":"75","author":"Barbieri","year":"2016","journal-title":"Magn Reson Med"},{"key":"10.1016\/j.phro.2024.100693_b0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.4097\/kja.d.18.00242","article-title":"What is the proper way to apply the multiple comparison test?","volume":"71","author":"Lee","year":"2018","journal-title":"Korean Journal Anesthesiol"},{"key":"10.1016\/j.phro.2024.100693_b0190","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.10387","article-title":"Comparing multiple comparisons: practical guidance for choosing the best multiple comparisons test","volume":"8","author":"Midway","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/j.phro.2024.100693_b0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.radonc.2022.07.020","article-title":"Repeatability of diffusion-weighted magnetic resonance imaging in head and neck cancer at a 1.5 T MR-Linac","volume":"174","author":"Habrich","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100693_b0200","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2021.09.020","article-title":"Accuracy and precision of apparent diffusion coefficient measurements on a 1.5 T MR-Linac in central nervous system tumour patients","volume":"164","author":"Lawrence","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100693_b0205","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2016.10.021","article-title":"The diffusion-weighted magnetic resonance imaging (DWI) predicts the early response of esophageal squamous cell carcinoma to concurrent chemoradiotherapy","volume":"121","author":"Wang","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.phro.2024.100693_b0210","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1088\/1361-6560\/aa5249","article-title":"Repeated diffusion MRI reveals earliest time point for stratification of radiotherapy response in brain metastases","volume":"62","author":"Mahmood","year":"2017","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.phro.2024.100693_b0215","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3174\/ajnr.A7567","article-title":"Normalized parameters of dynamic contrast-enhanced perfusion MRI and DWI-ADC for differentiation between posttreatment changes and recurrence in head and neck cancer","volume":"43","author":"Baba","year":"2022","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.phro.2024.100693_b0220","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ijrobp.2011.02.044","article-title":"Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma","volume":"82","author":"Vandecaveye","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100693_b0225","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3174\/ajnr.A7431","article-title":"ADC for differentiation between posttreatment changes and recurrence in head and neck cancer: a systematic review and meta-analysis","volume":"43","author":"Baba","year":"2022","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.phro.2024.100693_b0230","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1093\/neuonc\/nor200","article-title":"Relevance of T2 signal changes in the assessment of progression of glioblastoma according to the Response Assessment in Neurooncology criteria","volume":"14","author":"Radbruch","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.phro.2024.100693_b0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144770","article-title":"DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck","volume":"10","author":"King","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.phro.2024.100693_b0240","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1118\/1.4737022","article-title":"An approach to identify, from DCE MRI, significant subvolumes of tumors related to outcomes in advanced head-and-neck cancer","volume":"39","author":"Wang","year":"2012","journal-title":"Med Phys"},{"key":"10.1016\/j.phro.2024.100693_b0245","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1016\/j.ijrobp.2011.03.006","article-title":"Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases","volume":"82","author":"Shukla-Dave","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.phro.2024.100693_b0250","doi-asserted-by":"crossref","first-page":"S557","DOI":"10.1016\/j.annonc.2023.09.2002","article-title":"856MO A randomized phase II study of concurrent vs. sequential pembrolizumab with chemoradiation (CRT) in locally advanced head and neck cancer (LA HNSCC): 4-year results and tumor-immune microenvironment analysis","volume":"34","author":"Zandberg","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.phro.2024.100693_b0255","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1356153","article-title":"Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinoma","volume":"6","author":"Oweida","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.phro.2024.100693_b0260","doi-asserted-by":"crossref","unstructured":"Boustani J, Lecoester B, Baude J, Latour C, Adotevi O, Mirjolet C, et al. Anti-PD-1\/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies. Cancers (Basel) 2021;13. 10.3390\/cancers13194893.","DOI":"10.3390\/cancers13194893"},{"key":"10.1016\/j.phro.2024.100693_b0265","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mri.2024.02.008","article-title":"Intravoxel incoherent motion magnetic resonance imaging to assess early tumor response to radiation therapy: Review and future directions","volume":"108","author":"Mesny","year":"2024","journal-title":"Magn Reson Imaging"}],"container-title":["Physics and Imaging in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631624001635?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405631624001635?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T20:32:11Z","timestamp":1741984331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405631624001635"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":53,"alternative-id":["S2405631624001635"],"URL":"https:\/\/doi.org\/10.1016\/j.phro.2024.100693","relation":{},"ISSN":["2405-6316"],"issn-type":[{"value":"2405-6316","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative magnetic resonance imaging responses in head and neck cancer patients treated with magnetic resonance-guided hypofractionated radiation therapy","name":"articletitle","label":"Article Title"},{"value":"Physics and Imaging in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phro.2024.100693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of European Society of Radiotherapy & Oncology.","name":"copyright","label":"Copyright"}],"article-number":"100693"}}